Ruth Ann Marrie1, John R Walker2, Lesley A Graff2, Lisa M Lix3, James M Bolton4, Zoann Nugent5, Laura E Targownik6, Charles N Bernstein7. 1. Department of Internal Medicine, University of Manitoba, Winnipeg, Canada; Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada. 2. IBD Clinical and Research Centre, University of Manitoba, Winnipeg, Canada; Department of Clinical Health Psychology, University of Manitoba, Winnipeg, Canada. 3. Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada; IBD Clinical and Research Centre, University of Manitoba, Winnipeg, Canada; Manitoba Centre for Health Policy, Winnipeg, Canada. 4. Manitoba Centre for Health Policy, Winnipeg, Canada; Department of Psychiatry, University of Manitoba, Winnipeg, Canada. 5. IBD Clinical and Research Centre, University of Manitoba, Winnipeg, Canada. 6. Department of Internal Medicine, University of Manitoba, Winnipeg, Canada; IBD Clinical and Research Centre, University of Manitoba, Winnipeg, Canada. 7. Department of Internal Medicine, University of Manitoba, Winnipeg, Canada; IBD Clinical and Research Centre, University of Manitoba, Winnipeg, Canada. Electronic address: Charles.bernstein@umanitoba.ca.
Abstract
OBJECTIVES: Comorbid depression and anxiety are common in inflammatory bowel disease (IBD), but few population-based estimates of the burden of depression and anxiety exist. Methods to support population-based studies are needed. We aimed to test the performance of administrative case definitions for depression and anxiety in IBD and to understand what the prevalence estimated using such definitions reflects. METHODS: We linked administrative (health claims) data from the province of Manitoba, Canada with clinical data for 266 persons in the Manitoba IBD Cohort Study. We compared the performance of administrative case definitions for depression and anxiety with (a) diagnoses of depression and anxiety as identified based on the Composite International Diagnostic Interview (CIDI), which identifies disorders meeting formal diagnostic criteria, and (b) participant report of physician-diagnosed depression or anxiety. RESULTS: Administrative definitions for depression showed moderate agreement with the CIDI (κ=0.39-0.42). Agreement was higher with participant report of physician-diagnosed depression (κ=0.54). The lifetime prevalence of depression was 29.3% based on the CIDI, 17.7% based on participant report of physician-diagnosed depression, and 21.8-22.5% based on administrative data. Compared to the CIDI, administrative definitions for anxiety showed fair agreement (κ=0.21-0.25). The lifetime prevalence of anxiety was 31.2% based on the CIDI, 9.7% based on participant report of physician-diagnosed anxiety, and 24.4-31.9% based on administrative data. CONCLUSIONS: Administrative data may be used for population-level surveillance of depression and anxiety in IBD, although they will not capture undiagnosed or untreated cases.
OBJECTIVES: Comorbid depression and anxiety are common in inflammatory bowel disease (IBD), but few population-based estimates of the burden of depression and anxiety exist. Methods to support population-based studies are needed. We aimed to test the performance of administrative case definitions for depression and anxiety in IBD and to understand what the prevalence estimated using such definitions reflects. METHODS: We linked administrative (health claims) data from the province of Manitoba, Canada with clinical data for 266 persons in the Manitoba IBD Cohort Study. We compared the performance of administrative case definitions for depression and anxiety with (a) diagnoses of depression and anxiety as identified based on the Composite International Diagnostic Interview (CIDI), which identifies disorders meeting formal diagnostic criteria, and (b) participant report of physician-diagnosed depression or anxiety. RESULTS: Administrative definitions for depression showed moderate agreement with the CIDI (κ=0.39-0.42). Agreement was higher with participant report of physician-diagnosed depression (κ=0.54). The lifetime prevalence of depression was 29.3% based on the CIDI, 17.7% based on participant report of physician-diagnosed depression, and 21.8-22.5% based on administrative data. Compared to the CIDI, administrative definitions for anxiety showed fair agreement (κ=0.21-0.25). The lifetime prevalence of anxiety was 31.2% based on the CIDI, 9.7% based on participant report of physician-diagnosed anxiety, and 24.4-31.9% based on administrative data. CONCLUSIONS: Administrative data may be used for population-level surveillance of depression and anxiety in IBD, although they will not capture undiagnosed or untreated cases.
Authors: Edward L Barnes; Bharati Kochar; Millie D Long; Michael D Kappelman; Christopher F Martin; Joshua R Korzenik; Seth D Crockett Journal: Inflamm Bowel Dis Date: 2017-06 Impact factor: 5.325
Authors: Edward L Barnes; Bharati Kochar; Millie D Long; Christopher F Martin; Seth D Crockett; Joshua R Korzenik; Michael D Kappelman Journal: J Pediatr Date: 2017-10-14 Impact factor: 4.406
Authors: Charles N Bernstein; Carol A Hitchon; Randy Walld; James M Bolton; Jitender Sareen; John R Walker; Lesley A Graff; Scott B Patten; Alexander Singer; Lisa M Lix; Renée El-Gabalawy; Alan Katz; John D Fisk; Ruth Ann Marrie Journal: Inflamm Bowel Dis Date: 2019-01-10 Impact factor: 5.325
Authors: Usama Jazzar; Shan Yong; Zachary Klaassen; Jinhai Huo; Byron D Hughes; Edgar Esparza; Hemalkumar B Mehta; Simon P Kim; Douglas S Tyler; Stephen J Freedland; Ashish M Kamat; Dwight V Wolf; Stephen B Williams Journal: Cancer Date: 2018-04-16 Impact factor: 6.860
Authors: Kendiss Olafson; Ruth Ann Marrie; James M Bolton; Charles N Bernstein; O Joseph Bienvenu; Maia S Kredentser; Sarvesh Logsetty; Dan Chateau; Yao Nie; Marcus Blouw; Tracie O Afifi; Murray B Stein; William D Leslie; Laurence Y Katz; Natalie Mota; Renée El-Gabalawy; Murray W Enns; Christine Leong; Sophia Sweatman; Jitender Sareen Journal: Intensive Care Med Date: 2021-09-08 Impact factor: 17.440
Authors: Charles N Bernstein; Carol A Hitchon; Randy Walld; James M Bolton; Lisa M Lix; Renée El-Gabalawy; Jitender Sareen; Alexander Singer; Alan Katz; James Marriott; John D Fisk; Scott B Patten; Ruth Ann Marrie Journal: Inflamm Bowel Dis Date: 2021-08-19 Impact factor: 5.325
Authors: Ruth Ann Marrie; Randy Walld; James M Bolton; Jitender Sareen; John R Walker; Scott B Patten; Alexander Singer; Lisa M Lix; Carol A Hitchon; Renée El-Gabalawy; Alan Katz; John D Fisk; Charles N Bernstein Journal: BMC Res Notes Date: 2017-11-25
Authors: Ruth Ann Marrie; Carol A Hitchon; Randy Walld; Scott B Patten; James M Bolton; Jitender Sareen; John R Walker; Alexander Singer; Lisa M Lix; Renée El-Gabalawy; Alan Katz; John D Fisk; Charles N Bernstein Journal: Arthritis Care Res (Hoboken) Date: 2018-05-21 Impact factor: 4.794
Authors: Kyla N Brown; Andrea Soo; Peter Faris; Scott B Patten; Kirsten M Fiest; Henry T Stelfox Journal: Crit Care Date: 2020-07-31 Impact factor: 9.097